Program ANZTCT ASM 2024
Kindly note this is a working draft and speakers and session times are subject to change.
Thursday 5 September 2024
ANZTCT ASM 2024 - DAY 1
From 7:30am
Registration – Foyer, Endeavour Ballroom, Level 2
8:00am
Opening of ANZTCT ASM 2024
- Welcome to Country: Michael West
- Maori Address: Nadene Edmonds
- President’s Address
TCT takes a village - Chairs: Prof Nada Hamad and Prof David Yeung
8:40am
Keynote Presentation - Transplantation and Cellular Therapy: they take a village
- Prof Stephanie Lee - Fred Hutchinson Cancer Centre
9:30am
The ‘ village people’
- Dermatologist / Skin Care: Prof Pablo Fernandez-Penas
- Cardiologist: Dr Mark Nolan
- Gynecologist: Dr Jennifer Bradford
- Respiratory: Prof Peter Middleton
10:30am
Morning Tea - Sponsored by Arovella Therapeutics
11:00am
The ‘village people’ cont.
Chairs: Dr Shanti Ramachandran and Yvonne Panek-Hudson
- Oncofertility: A/Prof Antoinette Anazodo
- Benign Transplant: Dr Alisa Kane and AYA transition to adult care: Dr Melissa Gabriel
- Supportive Care for Paeds & AYA post CAR-T: Maddie Gilsenen
11:45am
Delegate Lunch
TCT Stakeholders Networking Lunch (11:45am - 12:45pm) - with Guest Speaker, The Hon Ged Kearney MP, Assistant Minister for Health and Aged Care - Sirius Room
(ANZTCT / ABMDR / ARROW / LF / Commonwealth / HPCC/ CHOs/Industry and Centre CEOs/HoDs) by invitation
Lunch ‘n’ Learn (12:45pm - 1:15pm) with Dr Bartlomiej Getta - Endeavour Ballroom
Chairs: A/Prof Ashish Bajel and A/Prof Andrea Henden
Chairs: John Coutsouvelis and Maddie Gilsenen
1:15pm
Oral Abstracts: Presidential
- Heather Dunckley - Matched unrelated donor haematopoietic cell transplants in Aotearoa New Zealand and the impact of HLA diversity
- Zulekha Khan - Rural/regional place of residence impacts post allogeneic bone marrow transplant overall survival of Australian patients with acute myeloid leukaemia: an ANZTCT Registry study
- Midori Nakagaki - A randomised trial of topical polaprezinc to prevent oral mucositis in patients undergoing haematopoietic stem cell transplantation
- Robert Weinkove - A Phase 1 Dose Escalation and Expansion Trial of Third-Generation CD19-Directed CAR T-Cells Incorporating CD28 and Toll-like Receptor 2 (TLR2) Co-Stimulation for Relapsed or Refractory B-Cell Non- Hodgkin Lymphomas (ENABLE-1)
- Mark Dowling - ANZTCT CART in NHL national outcomes report
- Valeriya Kuznetsova - Subacute cognitive and psychological recovery from the immune effector cell associated neurotoxicity syndrome following chimeric antigen receptor T-cell (CAR-T) therapy
2:15pm
The ‘village people’ cont.
- TBI is not all the same: Dr Jennifer Chard
- Ocular GVHD & dry eye disease: Prof Peter McCluskey
- Infection and IV Access: Prof Claire Rickard
- Getting rid of the neutropenic diet: Josephine Campbell
- International long term follow up guidelines: Nicole Loft and Alia Cibich
3:30pm
Afternoon Tea
Sponsored by Ontime Couriers GmbH
4:00pm
Oral Abstracts: TCT
- Trung Ngo - The role of salvage cellular therapy in primary graft failure post allogeneic stem cell transplantation
- Ashish Bajel - Desensitisation therapy for donor specific antibodies prior to allogeneic stem cell transplantation
- David Ritchie - Nivallo: A prospective phase I study of Nivolumab to promote the graft versus tumour effect in haematological malignancies persisting or progressing after allogeneic stem cell transplantation
- Nisha Thiagarajah - Real-world treatment outcomes in non-favourable risk AML - Data linkage between the ALLG National Blood Cancer Registry (NBCR) and the Australia and New Zealand Transplant and Cellular Therapy (ANZTCT) Registry
- Hilary Cahill - A single institute experience of secondary malignancies in survivors of childhood cancer: a retrospective review
5:00pm
Posters and Welcome Drinks
Friday 6 September 2024
ANZTCT ASM 2024 - DAY 2
8:00am
Keynote Presentation
- Prof Bronwen Shaw - CIBMTR, Medical College of Wisconsin
8:50am
ANZCTC Registry Updates
- Committee update: Leonie Wilcox - Registry Manager
9:00am
National Clinical Quality Registries Updates
- Clinical Quality Registries Framework Update: Suchit Handa - Program Director, Safety and Quality Improvement Systems
9:10am
FACT accreditation and ANZTCT Partnership
- Dr Phyllis Warkentin - FACT Chief Medical Officer
9:25am
- Safety and Quality Improvement Systems at ACSQHC: Suchit Handa
9:40am
NZ TCT Quality achievements
- Dr Alwyn D’Souza - Capital & Coast District Health Board, NZ
10:00am
Morning Tea - Sponsored by Arovella Therapeutics
10:30am
Panellists:
- Prof David Ritchie - Royal Melbourne Hospital
- Prof Joy Ho - University of Sydney and Royal Prince Alfred
- Dr Clinton Lewis - Auckland City Hospital
- Peter Jansen - Chief Executive, NZ HQSC
11:30am
Chairs: Richelle Koller and Yvonne Panek-Hudson
- Awardee announcements
- Arrow Scholarship abstract - Leah Peters
- Arrow Scholarship abstract - Sanjana Rangi
12:00pm
Delegate Lunch
Chairs: A/Prof Andrea Henden and Prof David Ritchie
CAR T in Clinical Context - Chairs: Dr Salvatore (Sam) Fiorenza and Prof Joy Ho
1:30pm
Keynote Presentation: CAR-T in Myeloma
- A/Prof Andrew Cowan - Fred Hutchinson Cancer Centre
2:10pm
Panel Discussion
Moderated by Dr Salvatore (Sam) Fiorenza
Panelists:
- Prof Andrew Spencer - The Alfred
- Nurse: Dr Tracy King - Royal Prince Alfred and University of Sydney
- Patient: Dr Nigel Rosen
2:30pm
Afternoon Tea
Sponsored by Ontime Couriers GmbH
3:00pm
The sequence of events: Novel agents and TCT
Chair: Prof Paula Marlton
- CAR-T is already dying in NHL?: Dr Ed Abadir (Affirmative) vs Dr Rob Weinkove (Negative)
- Only Allo BMT cures ALL: Dr Ashley McEwan (Affirmative) vs Dr Seong Lin Khaw (Negative)
- Cellular Therapy is Required to cure CLL: A/Prof Mary Ann Anderson (Affirmative) vs Dr Othman Al-Sawaf (Negative)
4:30pm
- Nicole O'Leary - Pre-infusion risk factors in LBCL and considerations for outpatient delivery of Axicabtagene
- Sam van der Linde - Nursing-led model of care for cytopenias post CAR T-cell therapy in R/R large b-cell lymphoma - a single centre experience
- Yi Vee Chew - Long-distance transport of HPC followed by cryopreservation does not adversely impact post-thaw viable CD34 recoveries and patient outcomes
- Tania Wallace - Psychological distress in allogeneic haematopoietic stem cell transplant patients with graft-versus host disease - A systematic review
- Daniel Kilmartin - Quality improvements in the digital age
5:30pm
Delegate break
6:30pm
ASM Dinner at Le Sands Restaurant
Paint The Town RED with Arrow
Saturday 7 September 2024
ANZTCT ASM 2024 - DAY 3
From 8:00am
Registration
Beyond the Cells: The Future and Sustainability of TCT - Chairs: Dr Rob Weinkove and Rhys Hibbert
8:30am
Patient opening statement
- Rhys Hibbert
8:40am
Donor Sourcing - how that works
- Lisa Smith - ABMDR on donor recruitment
9:00am
Equity, diversity and inclusion in TCT
- Intersectionality in TCT: Prof Nada Hamad
- Australian Indigenous perspectives: Prof Maree Toombs
- New Zealand Indigenous perspectives: Dr Myra Ruka
9:45am
Advocacy Initiatives
- Vaccination access and advocacy: Megan Hogg
- Immigration challenges in TCT: Dr Jessica Ling
- Access to resources - GvHD and long term follow up: Nicole Loft
10:30am
Morning Tea - Sponsored by Arovella Therapeutics
11:00am
Panel Discussion: The future of TCT - Policy and strategic planning
Moderated by: Prof Nada Hamad
Panellists:
- Economist: Prof Richard De Abreu Lourenco
- Government Rep: Dr Alicia Veasey
- Nurse: Yvonne Panek-Hudson
- Scientist: Dr Annette Trickett
- Medical: Prof David Ritchie
12:00pm
Delegate Lunch
Setting ANZ standards in Clinical Practice - Chairs: Prof Rosemary Harrup and Bill Stavreski from Leukaemia Foundation
1:30pm
Clinical Practice Position Statements updates
- GVHD, VOD, CMV: A/Prof Andrea Henden
- Other Practice Statements: Prof Nada Hamad
– Optimisation of pre BMT AML disease response, Auto/Allo/CAR-T in NHL, Infection/EDI/Consent
1:50pm
ANZTCT Committees and Special interest groups
- Nursing Committee: Megan Hogg
- Pharmacy interest group: Dr John Coutsouvelis
- TBI interest group: Dr Lotte Fog
- Quality Manager interest group: Elissa Northridge
- Data Manager interest group: Dr Xiaobin Zhan
2:20pm
ANZTCT ASM Close
2:30pm
Afternoon Tea
Sponsored by Ontime Couriers GmbH (followed by the CLL Satellite Symposium)
Saturday 7 September 2024
ANZTCT CLL SATELLITE SYMPOSIUM
2:30pm
Registration and Afternoon Tea - Foyer, Endeavour Ballroom, Level 2
Sequencing in CLL - Chair: Dr Gavin Cull
3:00pm
1L Strategies
- Dr Othman Al-Sawaf
3:20pm
RR CLL
- Dr Sasanka Handunnetti
3:40pm
Panel Discussion
- Dr Gavin Cull, Dr Xavier Badoux, Dr Othman Al-Sawaf, Dr Sasanka Handunnetti
4:00pm
The current state of play for RT
- Dr Masa Lasica
4:15pm
Panel Discussion
- Dr Philip Thompson, Dr Masa Lasica, Dr Othman Al-Sawaf, Dr Denise Lee
Curative Strategies in CLL - Chair: Prof Paula Marlton
4:30pm
Allograft
- Prof David Ritchie
4:45pm
CAR-T
- Dr Rob Weinkove
5:00pm
Novel combinations including bispecifics
- Prof Stephen Mulligan
5:15pm
Panel Discussion
- Prof Paula Marlton, Prof David Ritchie, Dr Rob Weinkove, Prof Stephen Mulligan, Dr Othman Al-Sawaf, Prof Rosemary Harrup
From 5:30pm
Closing drinks followed by faculty dinner
Kindly note this is a working draft and speakers and session times are subject to change.